Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COAST
ISRCTN83689269Phase 2Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Oct 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in cancer comparing Aspirin + omeprazole with Placebo comparator (2 arms). Primary endpoint: Primary: Total difference in hearing before and 7 days after treatment. Started Oct 2012; status: completed.
02
Drugs
aspirinomeprazole
03
Conditions
cancer
Beyond the preview
Go deeper on ISRCTN83689269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN83689269.